Organon & Co. (OGN)

USD 11.2

(3.47%)

Total Liabilities Summary of Organon & Co.

  • Organon & Co.'s latest annual total liabilities in 2023 was 12.12 Billion USD , up 2.37% from previous year.
  • Organon & Co.'s latest quarterly total liabilities in 2024 Q2 was 12.01 Billion USD , up 1.41% from previous quarter.
  • Organon & Co. reported annual total liabilities of 11.84 Billion USD in 2022, down -2.81% from previous year.
  • Organon & Co. reported annual total liabilities of 12.18 Billion USD in 2021, up 8.31% from previous year.
  • Organon & Co. reported quarterly total liabilities of 12.25 Million USD for 2024 Q3, up 2.07% from previous quarter.
  • Organon & Co. reported quarterly total liabilities of 12.01 Billion USD for 2024 Q2, up 1.41% from previous quarter.

Annual Total Liabilities Chart of Organon & Co. (2023 - 2018)

Historical Annual Total Liabilities of Organon & Co. (2023 - 2018)

Year Total Liabilities Total Liabilities Growth
2023 12.12 Billion USD 2.37%
2022 11.84 Billion USD -2.81%
2021 12.18 Billion USD 8.31%
2020 11.25 Billion USD 220.35%
2019 3.51 Billion USD -15.27%
2018 4.14 Billion USD 0.0%

Peer Total Liabilities Comparison of Organon & Co.

Name Total Liabilities Total Liabilities Difference
AbbVie Inc. 124.31 Billion USD 90.244%
Bristol-Myers Squibb Company 65.67 Billion USD 81.533%
Bristol-Myers Squibb Company Ce 65.67 Billion USD 81.533%
Johnson & Johnson 98.78 Billion USD 87.723%
Eli Lilly and Company 53.14 Billion USD 77.178%
Merck & Co., Inc. 69.04 Billion USD 82.433%
Novartis AG 53.19 Billion USD 77.201%
Pfizer Inc. 137.21 Billion USD 91.161%